Article Text

Download PDFPDF
Predictors of primary non-adherence to concomitant chronic treatment in HIV-infected patients with antiretroviral therapy
  1. Yolanda Borrego1,
  2. Encarnación Gómez-Fernández1,
  3. Rocío Jiménez1,
  4. Rosa Cantudo1,
  5. Carmen V Almeida-González2,
  6. Ramón Morillo1
  1. 1 Department of Pharmacy, Hospital Universitario Nuestra Señora de Valme, Seville, Spain
  2. 2 Biostatistician, Hospital Universitario Nuestra Señora de Valme, Seville, Spain
  1. Correspondence to Yolanda Borrego, Department of Pharmacy, Hospital Universitario Nuestra Señora de Valme, Seville, Spain; yolandaborrego77{at}hotmail.com

Abstract

Objectives To identify the independent risk factors of primary non-adherence to chronic concomitant treatment in HIV-positive patients, and to measure primary and secondary non-adherence rates to chronic treatments, and secondary non-adherence to antiretroviral therapy and the prevalence of concomitant chronic diseases.

Methods We conducted a retrospective study that included HIV-infected patients with antiretroviral treatmentwho attended the pharmaceutical care office between January and December 2012. The dependent variable was primary non-adherence to concomitant prescription drugs for chronic diseases. To know the predictors of concomitant primary non-adherence, we performed a univariate analysis and a multivariate binary logistic regression model to identify the independent predictors of primary non-adherence to co-medication.

Results Out of 598 patients analysed, 333 patients had a new co-medication prescribed during the studied period. The number of comorbidities per patient was 2.3 and the patients were treated with an average of 3.4 drugs. The rates of primary and secondary non-adherence to co-medication were 8.4% and 44.4%, respectively. The co-occurrence of primary and secondary non-adherence was 24.9%. The number of comorbidities (p=0.001) and co-medications (p=0.001) was significantly higher in patients who had primary non-adherence to co-medication. Furthermore, there was a statistically significant relationship between primary non-adherence and patients treated with psychotropic drugs (p=0.03). The multivariate analysis showed the independent predictor of primary non-adherence to co-medication was the number of co-medications (p<0.001).

Conclusion One-third of new concomitant medications prescribed to HIV-positive patients were never filled from the pharmacy. The number of co-medications was identified as a predictor of primary non-adherence to chronic concomitant treatment in HIV-infected population.

  • primary adherence
  • chronic disease
  • co-medication
  • HIV

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.